WO2000068670A1 - Method and system for remotely collecting and evaluating chemical/biochemical information - Google Patents

Method and system for remotely collecting and evaluating chemical/biochemical information Download PDF

Info

Publication number
WO2000068670A1
WO2000068670A1 PCT/US2000/012409 US0012409W WO0068670A1 WO 2000068670 A1 WO2000068670 A1 WO 2000068670A1 US 0012409 W US0012409 W US 0012409W WO 0068670 A1 WO0068670 A1 WO 0068670A1
Authority
WO
WIPO (PCT)
Prior art keywords
reactant
detector
sensor
fluid sample
interest
Prior art date
Application number
PCT/US2000/012409
Other languages
French (fr)
Other versions
WO2000068670A9 (en
Inventor
Eric V. Anslyn
Sherry L. Acanfora-Florin
Damon Borich
James W. Douglas
John T. Mcdevitt
John A. Mcmorris, Iii
Gregory A. Mullins
Dean B. Neikirk
Mike J. Otworth
John S. Scott
Jason B. Shear
Original Assignee
Anslyn Eric V
Acanfora Florin Sherry L
Damon Borich
Douglas James W
Mcdevitt John T
Mcmorris John A Iii
Mullins Gregory A
Neikirk Dean B
Otworth Mike J
Scott John S
Shear Jason B
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anslyn Eric V, Acanfora Florin Sherry L, Damon Borich, Douglas James W, Mcdevitt John T, Mcmorris John A Iii, Mullins Gregory A, Neikirk Dean B, Otworth Mike J, Scott John S, Shear Jason B filed Critical Anslyn Eric V
Priority to AU49905/00A priority Critical patent/AU4990500A/en
Publication of WO2000068670A1 publication Critical patent/WO2000068670A1/en
Publication of WO2000068670A9 publication Critical patent/WO2000068670A9/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/7703Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/62Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
    • G01N21/63Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
    • G01N21/64Fluorescence; Phosphorescence
    • G01N21/6428Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"

Definitions

  • the present invention relates to a method and device for the detection of
  • the analytes are localized at the end of a probe suitable for
  • the body of interest may include a wide variety
  • the body of interest may be the interior of an animal (which term is
  • a body of interest could also be a
  • the present invention allows one to acquire chemical/biochemical assays
  • the present invention includes a video
  • the present invention allows one to simultaneously acquire both optical information related to the condition of the body of interest, such as,
  • the present invention relates to the development of instrumentation
  • the for multiple analyte detection generally include an array of sensors.
  • the sensors have been fashioned using a number of distinct transduction schemes. If the sensors sample air, as opposed to fluid, the sensors are generally
  • Electronic noses generally include a housing
  • sensors is dependent on which analyte or how much of an analyte needs to be
  • the air sample is
  • the tube may be comprised of plastic or stainless steel. In this case
  • the air sample contacts the sensor array, causing the sensors to react in
  • sensor arrays is then utilized to detect in what ways each sensor reacts to that
  • a washing gas such as an alcohol vapor is applied to a washing gas.
  • a reference gas may be utilized to place each sensor to a
  • Typical electronic noses fall into five categories: conductivity sensors,
  • MOSFET metal oxide silicon field effect transistor
  • sensing devices optical sensors and spectrometry-based sensing methods.
  • conductivity sensors There are two types of conductivity sensors: metal oxide semiconductors
  • Metal oxide semiconductors have been
  • polymer sensors are also commonly used and are easier to make than metal
  • the metal may be tin, zinc, titanium,
  • tungsten or iridium one of which is doped with a noble metal catalyst such as
  • the doped semiconducting material is deposited between
  • the electrodes may be
  • the resistive heater is normally a
  • Patent No. 5,654,497 issued to Hoffheins et al. These sensors display the
  • the polymer is generally from polymer
  • VOC is introduced to the active material (either the metal oxide or the polymer
  • the resistance between the electrodes changes in proportion to the
  • the active polymer material changes in relation to its exposure to the VOC.
  • Another structure involves a series of conductive polymer layers
  • volatile reagents some of the volatile reagents adsorb onto the surface of the volatile reagents
  • response of a semiconductor may drift over a period of time, and that the
  • the second type of electronic noses are piezoelectric sensors.
  • Piezoelectric sensors may be quartz crystal microbalance devices or surface
  • acoustic wave (SAW) devices The quartz crystal microbalance devices are
  • the device resonates at a particular
  • polymer coating material is applied to the disk to serve as an active sensing
  • Surface acoustic wave devices are comprised of a piezoelectric
  • phase shift depends, in part, on the
  • quartz crystal microbalance devices may generate larger changes in
  • surface acoustic wave devices may be less sensitive than
  • the third type of electronic noses are MOSFET devices.
  • sensing devices generally include a p-type substrate with two n-doped regions
  • MOSFETs work on the principle
  • a volatile organic compound may produce a reaction in a metal when the compound contacts the metal.
  • the product of the reaction may diffuse through
  • MOSFET sensing devices have not been commonly
  • MOSFET sensing devices is that they can be made with IC fabrication
  • MOSFET sensing devices is the need for the reaction products to penetrate the
  • the sensing device must have a window to permit gas to
  • the fourth type of electronic noses are optical fiber sensors.
  • Optical fiber sensors are optical fiber sensors.
  • sensors are generally comprised of glass fibers with a thin chemically active
  • the active material responds
  • the active material contains chemically
  • a light sensor detects the
  • emitted light and the presence of an analyte may be determined.
  • antigen binding such that a specific molecule, and only that molecule, may be
  • the fifth type of electronic noses is based on spectrometry-based sensing
  • a sensor at the output detects a
  • sensors include those which have been referred to as "DNA on a chip,” as well
  • tongue sensors is beyond the scope of this invention, although systems based
  • optical methods have provided excellent detection limits for analysis of limited
  • Optic sensors for evaluating one or more analytes in a fluid sample are
  • this patent discloses a support member with an optic array of
  • sensing receptor units positioned on the support member, wherein the sensing
  • receptor units react spectrally different with individual analytes in order to detect
  • each optical fiber includes a single or a plurality of optical fibers.
  • the end of each optical fiber may
  • the optical fiber provides
  • a detector such as a charge
  • CCD coupled device
  • the senor is made of optical fibers, the sensor permits the
  • optical filters are not utilized to differentiate the return signal from
  • the signal-to-noise ratio further increases.
  • processing device i.e., the detector or camera, are located at the far or remote
  • patents require the optical fibers, wires, and tubes to stick out of the host body, and does not allow for a contained assembly to be inserted into a host body.
  • optical fibers Furthermore, an additional disadvantage of the optical fibers is that there is
  • diagnostics detect an array of various analytes ranging from antibodies
  • structures e.g., epitopes on the organism, antigen or analyte being tested.
  • tests of this type ranges from 10 to 120 minutes, and often involves additional
  • reaction preparation time depending on the method of detection.
  • spectrophotometric methods are used to determine if an antigen-antibody
  • the sensors be adaptable to the simultaneous detection of a variety of analytes
  • the sensors provide real-time or near real-time feedback to facilitate
  • MRI Magnetic Resonance Imaging
  • CABG Coronary Artery Bypass Graft
  • equipment may be constructed to be compact, multi-task oriented, minimally
  • the present invention is directed to a method of detecting an analyte in a
  • the method includes the step of analyzing the fluid sample integral
  • the detector may be integral with the sensor by forming the sensor and the
  • the optical path is
  • the analyzing step includes the step of providing, for the sensor, a
  • the fluid sample is
  • a light source comprising one or more portions of
  • the electromagnetic spectrum is transmitted to the reactant.
  • the detector is then
  • the present invention may include a plurality of reactants. Each reactant
  • more than one reactant may be placed at at least one of the plurality of spatially
  • the substrate defines a plurality of cavities
  • each reactant is placed in at least one of the plurality of
  • the reactant is selected from the group consisting of a sensing particle, a
  • receptor molecule attached to a sensing particle, a gel or a reactive material.
  • the sensing particle is selected from the group consisting of functionalized
  • the receptor molecule is selected from the group consisting of signaling proteins, chemically sensitive dyes, nucleic acid strands,
  • nucleotide sequences include nucleotide sequences, biological binding agents, antibodies, antigens, organic molecules, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, organic amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids, amino acids
  • the substrate is comprised of glass, plastic,
  • the reactant is a fluorescent based reactant
  • light source is selected such that the frequency and wavelength of the light
  • the reactant is a coiorimetric based reactant
  • the light source is a portion of the electromagnetic spectrum.
  • the detector monitors the reactant as the fluid sample engages the
  • the present invention is directed to a method of
  • the method includes providing a physical assembly.
  • the physical assembly
  • the sensor includes a sensor, a detector and an illumination source.
  • the sensor includes a
  • a reactant is associated with at least one of the plurality of spatially distinct locations.
  • the reactant is interacted with a fluid sample.
  • a light source
  • the detector is used to monitor the reactant to detect an analyte while
  • the detector is proximally located to the region where the fluid sample is present.
  • the method includes means for retrieving
  • retrieving optical information includes a video monitor.
  • the method includes drive and interface
  • the physical assembly may be a
  • the detector is used to monitor the
  • the present invention is directed to a method of
  • detecting an analyte in a fluid sample within a biological system including
  • the detector which is integral with the sensor.
  • the sensor and the integral detector are inserted into the biological system to be proximally located to the fluid
  • the detector detects the analyte present in the
  • the biological system may be a mammalian body, such as a human, either
  • the senor and the detector are integrated
  • the present invention is also directed to a device for detecting an analyte
  • the device in a fluid sample integral to a region of interest.
  • the device includes a physical
  • the physical assembly includes a sensor, a detector which is integral
  • the senor is comprised of a substrate
  • the detector may be integral with the sensor by forming the sensor and
  • the detector in a common structure, by attaching the detector to the sensor, or
  • the optical path from the sensor to the detector.
  • the optical path from the sensor to the detector.
  • the device preferably includes a plurality of reactants, wherein each reactant is placed at at least one of the plurality of spatially distinct locations or
  • more than one reactant is placed at at least one of the plurality of spatially distinct
  • the substrate defines a plurality of cavities
  • each reactant is placed in at least one of the plurality of the plurality of the plurality of reactants
  • the reactant is selected from the group consisting of a sensing particle, a
  • receptor molecule attached to a sensing particle, a gel or a reactive material.
  • sensing particle is selected from the group consisting of functionalized polymeric
  • the receptor molecule is selected from the group consisting of
  • the substrate is comprised of glass, plastic, silicon, resin, polymer,
  • the reactant is a fluorescent based reactant
  • the light source is selected such that the frequency and wavelength of the light compliments the excitation band of the selected fluorescent based reactant.
  • the reactant is a coiorimetric based reactant
  • the light source is a portion of the electromagnetic spectrum.
  • the light source is
  • the device includes means for retrieving optical
  • the region of interest which is preferably a video monitor.
  • the physical assembly may be a probe, or may be spheroidal in shape.
  • the senor and the detector are integrated with a catheter to
  • Figure 1 is a perspective view of one embodiment of the present invention
  • Figure 2 is a perspective view of one embodiment of the present invention
  • Figure 3 is a perspective view of one embodiment of the present invention.
  • Figure 4 is a perspective view of one embodiment of the present invention.
  • Figure 5 is perspective view of one embodiment of the sensor of the
  • Figure 6 is a side view of the sensor shown in Figure 5, with a detector and illumination source.
  • the present invention is directed to method and system for analysis of a
  • the body of interest may be an animal (e.g., a human, a mammal, a human, or a mammal, a human, or a mammal, a mammal, or a human, a mammal, or a human, or a human.
  • the body of interest may be an animal (e.g., a human, or a human).
  • mammals such as humans, dogs and cows, and other animals such as fish
  • fish or a
  • body of interest could also be a food product, or the wash of a food product.
  • the present invention may be used for either gaseous fluids or liquid fluids.
  • the present invention may utilize either “electronic nose” or “electronic
  • the present invention may utilize any type of electronic nose sensor, including, but not limited to, conductivity sensors,
  • MOSFET metal oxide silicon field effect transistor
  • the present invention may utilize any type of sampling liquid samples
  • probe arrays conducting polymer gas sensors
  • acoustic wave gas sensors
  • field-effect gas sensors electrochemical gas sensors; pellistors; fiber optic gas
  • invention is configured to allow one to combine a type of electronic tongue sensor
  • the detector includes, but is not
  • optical detectors such as, for example, complementary metal oxide
  • CMOS complementary metal-oxide-semiconductor
  • OLED organic light detectors
  • infrared detectors fluorescent detectors
  • ultraviolet detectors ultraviolet detectors
  • CCD charge coupled device
  • the device of the present invention is suitably configured such that the
  • detector is integral with the sensor in a common structure. In this manner, the actual detection of analytes takes place while the sensor and detector are
  • the sensor and detector may be integral with each other.
  • the sensor and detector may be integral with each other.
  • the sensor and detector may be integral with each other.
  • the sensor and detector may be integral with each other.
  • detector may be formed in a common structure, such as, for example, in the same
  • the detector may be attached to the sensor through any combination
  • attachment mechanisms including, but not limited to, the use of
  • the detector may be situated near the
  • the detector is situated below
  • the sensor such that light from the sensor is transmitted to the detector.
  • the method and system of the present invention includes a sensor which
  • substrate is any material capable of having a reactant incorporated therewith.
  • the substrate In one embodiment, the reactant is attached to the substrate. In one embodiment, the reactant is attached to the substrate.
  • the reactant is intercalated within the substrate.
  • the plurality of spatially distinct locations one of the plurality of spatially distinct locations.
  • substrate defines a plurality of cavities, with at least one cavity being positioned at
  • reactant may be placed in at least one of the cavities or, in the alternative, more
  • than one reactant may be placed in one of the cavities.
  • locations are comprised of locations spaced apart from one another on the
  • These locations may be in an ordered array or may be unordered.
  • the reactant is any material capable of interacting with an analyte that
  • the reactant may be a sensing particle, a receptor molecule attached to
  • a sensing particle a gel, or a reactive coating.
  • the method of analyzing a fluid sample for an analyte of interest includes
  • a sensor preferably comprised of a substrate having a plurality of spatially
  • the fluid sample is interacted
  • the reactant will absorb electromagnetic radiation at one or more frequencies.
  • the detector is used to monitor the reactant to sense
  • the present invention may be utilized in a wide variety of applications to
  • invention is configured to be able to be placed in the specific region of interest
  • the present invention may be utilized
  • the present invention may be used to isolate the presence of specific
  • biochemical markers such as cardiac or tumor markers
  • the present invention may
  • lipid laden plaque versus other plaques inside cardiac arterial walls, thereby providing clinicians with diagnostic data that can help determine patient
  • the present invention will be capable of performing a multitude of varying conditions
  • the present invention requires minimal sample volume and
  • ICU critical care
  • Diabetic Keto-Acidosis consists almost entirely of correcting fluid
  • invention would provide one the ability to monitor, in real-time, electrolytes, blood
  • DIC Intravascular Coagulopathy
  • present invention could monitor parameters associated with developing a
  • Coagulopathy such as fibrinogen and fibrin split products, could simultaneously serve as fibrinogen and fibrin split products.
  • the second area in which the present invention would provide great improvement in current medical diagnostic capabilities is with its integration with
  • Helicobacter pylori he or she may be able to avoid an unnecessary biopsy for
  • a physician would be able to both visualize an area of interest
  • Colonoscopy is characteristically used to survey anatomical
  • aberrations such as, for example, neoplasms and polyps and local area of
  • CEA carcino-embryonic antigen
  • cytokines for indicators of specific inflammatory diseases such as, for example,
  • the clinician may be able to enhance his or her
  • the present invention could provide information regarding the
  • a patient undergoing an aortic arch vascular repair often has
  • myocardial infarction such as, for example, CK-MB, would help eliminate "silent
  • the present invention may be utilized in food safety applications.
  • the present invention could be utilized to detect
  • neurotoxins five endocrine disruptors, and five 'toxicity one' chemicals.
  • rBGH hormone
  • the present invention may be used to solve
  • test liquid food products such as milk, for example, to monitor for pesticides,
  • the present invention may be used in ruminant
  • BSE Bovine Spongiform Encephalopathy
  • genetically modified crops actually concentrate toxins, or in some cases, express
  • the present invention could be used to monitor for
  • Bacterial contamination is a significant health risk that is often caught after
  • the present invention could innovate the
  • pesticides include hormones, antibiotics, specific fungal toxins (such as aflatoxin), and
  • Food grading is another area where the present invention would be of use. This system can be used in meats to detect lipid levels and other factors that
  • detect factors such as, for example, specific oil and sugar levels.
  • the present invention is able to detect both an individual analyte and
  • the present invention includes a plurality of
  • the present invention may be either reusable, assuming the reactants
  • Figures 1 and 2 illustrate embodiments of a system of the present
  • Such a system can be
  • the system 100 includes a sensor structure
  • a physical assembly 102 for proximally placing the sensor in a region of
  • the system 100 includes
  • FIGS. 3 and 4 illustrate embodiments of a
  • system 110 of the present invention for detecting analytes in a liquid fluid sample.
  • Such a system may be ufilized to detect liquid-born analytes, including, but not
  • bacteria in a sample such as a fluid sample in a gastric ulcer or lungs; detecting
  • liquid food products such as, for example, milk, juices,
  • the system 110 includes a sensor structure
  • the electronics 115 The sensor 111 , the detector 112 and the illumination source
  • either the sensor 111 , the detector 112 and/or the illumination source 113 may be formed in a common structure with the physical assembly 114, such
  • detector 112 and/or the illumination source 113 may be attached to the physical
  • the drive and interface electronics 115 are connected either indirectly
  • the detector 112 is positioned below the sensor structure 111 to allow for data
  • the system 110 includes video pick-up
  • the system 110 includes a filter assembly 116 that removes the excitation
  • a preferred sensor structure is based on utilizing a sensor
  • the reactant experiences spectroscopic
  • the reactant is a plurality of chemically sensitive
  • the reactants produce coiorimetric or fluorescence signals upon
  • the sensor structure includes
  • reactants examples include, but are not limited to, functionalized
  • polymeric beads e.g., polystyrene-polyethylene-giycol (PS-PEG) resin beads
  • metal oxides particles e.g., silicon dioxide [SiO 2 ] or aluminum oxides
  • metal quantum particles e.g., silver, gold, platinum,
  • semiconductor quantum particles e.g., Si, Ge, GaAs, etc.
  • agarose
  • the reactant selected will be ideally suited to detect
  • the reactant is a sensing particle, such as, for example, PS-PEG resin beads.
  • a PS-PEG matrix is based on its choice of a PS-PEG matrix
  • the reactant is a receptor molecule synthesized
  • receptor molecule chosen depends on which analyte one wants to detect.
  • surface of the sensing particle include a wide variety of molecules, including, but
  • signaling proteins e.g., antigens, antibodies, and enzymes
  • binding agents e.g., avidin/biotin, lectins, and chelators
  • organic/inorganic binding agents e.g., avidin/biotin, lectins, and chelators
  • the sensing particles have diameters in the range of 1
  • - 500 microns and may actually change size (e.g., swell or shrink) when exposed
  • amount of lipid material may cause non-polar particles to change in volume when
  • the particles are exposed to such a fluid.
  • the senor includes a substrate having a plurality of
  • the substrate is a support member 120 configured to include the reactants.
  • support member 120 is preferably used to localize the reactants, as well as to
  • support member 120 is preferably made of any material capable of supporting the
  • the support member 120 is also made of a material substantially
  • the support member 120 may be
  • metals resins, polymers, fiber composites, metals, metal alloys, ceramics or any combination thereof
  • the support member 120 preferably includes
  • the cavities 130 are formed such
  • a plurality of particles are contained within a single cavity
  • the system 110 includes a detector 112 and an illumination source 113. As shown in Figure 5,
  • the illumination source 113 preferably passes through the sensor structure or
  • the light source 113 is a wavelength tailored and preferably filtered source, such
  • LED light emitting diode
  • a high intensity blue LED is
  • the light source 113 is preferably a "white" light. In one embodiment,
  • the light is delivered proximate to the sensor through a fiber optic assembly (not
  • Monitoring the spectroscopic changes to the reactants is preferably
  • microprocessor such as microprocessor 140 shown in Figure 6) (or other optical components
  • the detector 112 measures changes in the optical characteristics which
  • optical detectors including, but not limited to, charged coupled detectors (CCD), CCD
  • ultraviolet detectors or fluorescent detectors may be used.
  • the system 110 of the present invention includes a sensor structure 111
  • the physical assembly 114 is used to place the sensor
  • the physical assembly 114 is configured to be inserted through
  • an opening in the biological system such as, for example, an existing orifice or
  • the senor structure 111 and the senor structure 111 are identical to the region of interest.
  • detector 112 are integrated into a typical catheter that is used to provide central
  • assembly 114 must be of a shape and size that permits it to be delivered proximate to the region of interest with minimal invasive effects, typically requiring
  • the overall diameter to be 15 mm or less.
  • the physical assembly 114
  • assembly 114 has the shape of a probe. In another embodiment, the physical
  • assembly 114 is spheroidal in shape.
  • illumination source In addition to the sensor structure 111 , detector 112, illumination source
  • the system 110 includes drive and interface
  • interface electronics 115 are indirectly connected to the physical assembly 114.
  • physical assembly may include, but is not limited to, utilizing wires.
  • the drive and interface electronics 115 include, but are not limited to, well
  • the present invention includes means for
  • present invention preferably includes optical video technology that acquires and
  • video pick-up assembly 104 or 117 allows one to view the area where the
  • 104 or 117 is preferably a video monitoring system to allow one to view the region
  • optical sensors may be based upon coiorimetric or fluorescent
  • the senor is generally made up of reactants which experience spectroscopic changes after interacting with an analyte of
  • a detector is utilized to detect the
  • bit (8 bit x 3 color planes) video camera (not shown) is preferably used to detect
  • the reactant changes, providing the ability to acquire images at a rate of
  • characterization of reactants such as, for example, micro-sphere sensors.
  • the spectral information is acquired from
  • the detector in a format where the white light has been simplified, for instance, by assigning relative intensity values to three key wavelength regions, namely red-
  • CIE L'Eclairage
  • underivatized particles is taken as 100% transmittance.
  • T R G B is defined at the transmitted intensity through a particle in a particular
  • T 0 is the average background
  • aqueous analytes can penetrate into the polymer particles, that the particles are
  • source and the sensor operating frequency and wavelength include the receptor
  • Fluorescent based diagnostic assays operate under the same general
  • the reactant emits a fluorescent rather than
  • an optical detector such as, for example, a CCD detector.
  • the information is obtained from optical photomicrographs that
  • micro-spheres are virtually transparent across the entire visible region
  • the four different micro-spheres were tagged with: (1) underivatized, (2)
  • o-cresolphthalein complexone (3) alizarin complexone, and (4) fluorescein.
  • each type of micro-sphere displays spectral features
  • cresolphthalien micro-spheres display significant color attenuation only in the two
  • the color attenuation is less significant.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Plasma & Fusion (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)

Abstract

The present invention provides a method and system for detecting analytes in a fluid sample in a system of interest. The method and system includes a sensor, which includes at least one reactant, having an integral detector. The detector detects spectroscopic changes of reactants as the fluid sample passes over the reactants. The spectroscopic changes are caused by an analyte present in the fluid sample interacting with reactants.

Description

METHOD AND SYSTEM FOR REMOTELY COLLECTING AND EVALUATING CHEMICAL/BIOCHEMICAL INFORMATION
Priority Claim This application claims the benefit of U.S. Provisional Application No.
60/133,230, entitled Method and System for Remotely Collecting and Evaluating
Chemical/Biochemical Information, filed on May 7, 1999.
Background of the Invention
1. Field of the Invention
The present invention relates to a method and device for the detection of
analytes. Preferably, the analytes are localized at the end of a probe suitable for
insertion into a body of interest. The body of interest may include a wide variety
of materials, including, but not limited to, biological systems, both living and
dead. Thus, the body of interest may be the interior of an animal (which term is
understood to include humans) or a plant. A body of interest could also be a
food product, the wash of a food product, as well as agricultural and/or
environmental materials.
The present invention allows one to acquire chemical/biochemical assays
in localized regions, such as proximate to internal organs or the interior of blood
vessels of a human or animal body. If the present invention includes a video
monitoring system, the present invention allows one to simultaneously acquire both optical information related to the condition of the body of interest, such as,
for example, the condition of internal organs or blood vessels, while also
providing chemical/biochemical assays of these localized regions. More
particularly, the present invention relates to the development of instrumentation
that may be used for both surgical and microsurgical applications, wherein
minimally invasive procedures may be completed with a high degree of
accuracy.
2. Brief Description of the Related Art
The development of smart sensors capable of discriminating different
analytes, toxins, and bacteria has become increasingly important for a wide
range of applications, including environmental, health and safety, remote
sensing, food/beverage and chemical processing applications. Sensors have
been developed that may detect a single analyte or multiple analytes. Sensors
for multiple analyte detection generally include an array of sensors. The
advantages of these array sensor systems are their ability to analyze multiple
analytes, and their ability to be "trained" to respond to new stimuli through the
use of specific receptor molecules and the ongoing development of new types of
receptor molecules. The on-site adaptive analysis capabilities afforded by array
based sensors displaying the capacity to sense and identify complex vapors
have been fashioned using a number of distinct transduction schemes. If the sensors sample air, as opposed to fluid, the sensors are generally
referred to as "electronic noses." Electronic noses generally include a housing
for sampling the air sample, which includes the array of sensors, and a system
for detecting changes to the sensors of the array. The choice of the type of
sensors is dependent on which analyte or how much of an analyte needs to be
identified.
Typically, in the housing for sampling the air sample, the air sample is
pulled by a vacuum pump through a tube into a small chamber which houses the
array of sensors. The tube may be comprised of plastic or stainless steel. In this
manner, the air sample contacts the sensor array, causing the sensors to react in
particular ways to the air sample. The system for detecting changes to the
sensor arrays is then utilized to detect in what ways each sensor reacts to that
particular air sample.
In some instances, a washing gas such as an alcohol vapor is applied to
the array to remove the air sample from the active surface of the sensors. In re-
useable sensor arrays, a reference gas may be utilized to place each sensor to a
known state in order to introduce another air sample to the sensors.
Typical electronic noses fall into five categories: conductivity sensors,
piezoelectric sensors, metal oxide silicon field effect transistor (MOSFET)
sensing devices, optical sensors and spectrometry-based sensing methods. There are two types of conductivity sensors: metal oxide semiconductors
and conducting polymer sensors. Metal oxide semiconductors have been
utilized more extensively and are widely available commercially, but conducting
polymer sensors are also commonly used and are easier to make than metal
oxide semiconductors because they do not need a heating element.
For a metal oxide semiconductor, the metal may be tin, zinc, titanium,
tungsten or iridium, one of which is doped with a noble metal catalyst such as
platinum or palladium. The doped semiconducting material is deposited between
two electrodes over a resistive heating element. The electrodes may be
platinum, aluminum or gold, while the substrate in which the resistive heater is
placed may be silicon, glass or plastic. The resistive heater is normally a
platinum metal trace or wire. The use of tin oxide sensors is described in U.S.
Patent No. 5,654,497, issued to Hoffheins et al. These sensors display the
capacity to identify and discriminate between a variety of organic vapors by
virtue of small site-to-site differences in response characteristics.
For a conducting polymer sensor, the polymer is generally from polymer
families of polypyrroles, thiophenes, indoles or furans. The conducting polymer
is electropolymerized between two electrodes by cycling the voltage between the
electrodes. Because conducting polymer sensors operate at ambient
temperature, they do not need a resistive heating element. For both types of conductivity sensors, a volatile organic compound
(VOC) is introduced to the active material (either the metal oxide or the polymer
material) and alters the conductivity of the active material. The change in
resistance across the electrodes is then measured using conventional electronic
circuitry. For metal oxide semiconductors, as a VOC passes over the active
material, the resistance between the electrodes changes in proportion to the
concentration of the VOC. For conducting polymer sensors, the conductivity of
the active polymer material changes in relation to its exposure to the VOC.
Another structure involves a series of conductive polymer layers
deposited onto metal contacting layers. When these sensors are exposed to
volatile reagents, some of the volatile reagents adsorb onto the surface of the
polymer layers, leading to small changes in the electrical resistance of these
layers. One can identify and quantify the volatile reagents in the air sample by
detecting the small changes in the electrical resistance. This detection process
takes only a few seconds, and sensitivities of parts-per-billion may be achieved.
This electronic nose system is described in U.S. Patent No. 5,698,089, issued to Lewis et al.
Disadvantages with metal oxide semiconductors include that the baseline
response of a semiconductor may drift over a period of time, and that the
sensors are susceptible to poisoning by sulfur compounds present in the air sample. Disadvantages with conducting polymer sensors is the difficulty and
time that must be spent to electropolymerize the active material, which may
result in variations between batches of sensors. Also, these sensors also tend to
drift over a period of time, and they are sensitive to humidity, which may mask
the responses to certain odorous VOCs.
The second type of electronic noses are piezoelectric sensors.
Piezoelectric sensors may be quartz crystal microbalance devices or surface
acoustic wave (SAW) devices. The quartz crystal microbalance devices are
comprised of a small resonating disk with metal electrodes on each side of the
disk, which are connected to a lead wire. The device resonates at a particular
frequency when excited with an oscillating signal. During manufacture, a
polymer coating material is applied to the disk to serve as an active sensing
material. When an air sample is introduced to the disk, the air sample is
absorbed by the polymer coating material, which increases the mass of the
device and thereby reduces the resonance frequency. The reduction in the
resonance frequency is inversely proportional to the mass of the air sample
absorbed by the polymer coating material. The type of air sample to be tested
will determine the type of polymer coating material utilized, and there are a large
number of polymer coating materials available. Surface acoustic wave devices are comprised of a piezoelectric
substance that has a planar surface. Two metal transducers are placed onto the
planer surface, on either side of a polymer coating material. A surface wave
travels over the planar surface of the device by applying an AC signal across one
of the metal transducers. When the surface wave reaches the second metal
transducer, the AC voltage is recreated, although the voltage is shifted in phase
as a result of the distance traveled. The phase shift depends, in part, on the
mass and absorption properties of the polymer coating material, which are
influenced in turn by the gas molecules absorbed.
Surface acoustic wave devices operate at much higher frequencies than
quartz crystal microbalance devices, and thus may generate larger changes in
frequency. However, surface acoustic wave devices may be less sensitive than
quartz crystal microbalance devices because the increased surface to volume
ratios means than signal to noise ratios are generally poorer. Disadvantages
with both types of piezoelectric sensors are their need for more complex
electronics as compared to conductivity sensors.
The third type of electronic noses are MOSFET devices. MOSFET
sensing devices generally include a p-type substrate with two n-doped regions
with metal contacts labeled source and drain. MOSFETs work on the principle
that a volatile organic compound may produce a reaction in a metal when the compound contacts the metal. The product of the reaction may diffuse through
the gate of the MOSFET to change the electrical properties of the device. The
sensitivity and selectivity of the MOSFET sensing devices depends on the type
and thickness of the metal utilized and operating the particular devices at
different temperatures. MOSFET sensing devices have not been commonly
utilized in commercial electronic nose systems. However, an advantage to
MOSFET sensing devices is that they can be made with IC fabrication
processes, thereby reducing batch to batch variations. A disadvantage to
MOSFET sensing devices is the need for the reaction products to penetrate the
metal layer. Thus, the sensing device must have a window to permit gas to
interact with the gate structure on the IC chip. Moreover, it is important to
maintain a seal for the chip's electrical connections in harsh environments.
The fourth type of electronic noses are optical fiber sensors. Optical fiber
sensors are generally comprised of glass fibers with a thin chemically active
material coating on the sides or ends of the fibers. The active material responds
with a change in color to the presence of volatile organic compounds. A light
source comprising one or more portions of the electromagnetic spectrum is
utilized to illuminate the active material. The active material contains chemically
active fluorescent dyes immobilized in an organic polymer matrix. As volatile
organic compounds interact with the active material, the polarity of the dyes is altered, and the dyes shift their fluorescent emission spectrum. When a pulse of
light from the light source interrogates the active material, the fluorescent dye
responds by emitting light at a different frequency. A light sensor detects the
emitted light and the presence of an analyte may be determined.
Advantages to optical sensors are that they are cheap and easy to
fabricate. In addition, it is possible to combine a fluorescent dye to antibody-
antigen binding, such that a specific molecule, and only that molecule, may be
detected. Disadvantages to optical sensors are the complexity of the
instrumentation control system, which makes these sensors cost more to
produce, as well as their limited life due to photobleaching.
The fifth type of electronic noses is based on spectrometry-based sensing
methods. For one type of spectrometer, a concentrated vapor is injected into the
spectrometer, and the spectrometer generates a spectral response which is
characteristic of that vapor. In another type, acousto-optic tunable filters are
utilized. These filters alter their light-filtering characteristics in response to a
change in voltage across their light transmission path. If the voltage is varied,
the transmission path of the light through the filter changes, as does the peak
wavelength of the light. The result is a time-varying signal that is a function of
the light spectrum of the incoming source. A sensor at the output detects a
characteristic profile for each odorant being examined. There are a wide variety of additional electronic nose sensor types whose
general operation is known to those practiced in the art. In all cases, however, it
should be recognized that a relatively small number of carefully chosen sensors
can effect tremendous discrimination between different compounds. Moreover,
each of the technologies discussed above lends themselves to miniaturization
and, in principle, can be combined with the electronic tongue components
discussed in the present application.
In many applications, it is necessary to identify and quantify analytes
present in either liquid or solid phase samples. In these applications, the sensor
is sometimes referred to as an "electronic tongue." Types of electronic tongues
sensors include those which have been referred to as "DNA on a chip," as well
as thin films, dyes or beads that act as receptor units, conducting polymers, and
pulse spectroscopy cells. A full description of each of these types of electronic
tongue sensors is beyond the scope of this invention, although systems based
on "DNA on a chip" technology and systems using thin films, dyes or beads that
act as receptor units are discussed herein. It is assumed that one of skill in the
art is familiar with these types of sensors.
Array sensors based on "DNA on a chip" technology have shown great
analytical promise. These devices possess a high density of DNA hybridization
sites that are affixed in a two-dimensional pattern on a planar substrate. To generate nucleotide sequence information, a pattern is created from unknown
DNA fragments binding to various hybridization sites. Both radiochemical and
optical methods have provided excellent detection limits for analysis of limited
quantities of DNA. Proceedings of the National Academy of Science, USA,
Stimpson, D.I.; Hoijer, J.V.; Hsieh, W.; Jou, C; Gardon, J.; Theriault, T.; Gamble,
R.; Baldeschwieler, J.D., 92, 6397 (1995). Although quite promising for the
detection of DNA fragments, these arrays have the disadvantage of having very
little sensitivity to smaller organic molecules. In addition, many of the analytes of
interest do not contain DNA components, and would thus not be detectable by
this type of sensor. Thus, there is a need for a flexible, non-DNA based sensor.
Optic sensors for evaluating one or more analytes in a fluid sample are
known in the art. For example, a system of analyzing fluid samples using an
array formed of heterogeneous, semi-selective thin films which function as
sensing receptor units is described in U.S. Patent No. 5,512,490, issued to Walt
et al. In particular, this patent discloses a support member with an optic array of
sensing receptor units positioned on the support member, wherein the sensing
receptor units react spectrally different with individual analytes in order to detect
analytes of interest.
Similarly, another way to analyze fluid samples is based on using optical
fibers to carry a plurality of dyes or beads where the dyes or beads function as sensing receptor units, such as described in, for example, U.S. Patents Nos.
5,244,636, issued to Walt et al. (dyes) and U.S. Patent No. 6,023,540, issued to
Walt et al. (beads) (hereafter "the Walt et al. patents"). Typically, the device
includes a single or a plurality of optical fibers. The end of each optical fiber may
be etched to form indentations. The beads are placed into these indentations, or
the dyes are deposited on the end of the optical fiber. The optical fiber provides
illumination to transmit light to the beads or dyes. A detector, such as a charge
coupled device (CCD) detector, detects the light emerging from the beads or
dyes to determine whether an analyte of interest is present in the fluid sample.
The Walt et al. patents disclose analyzing fluid samples in in vivo or in
vitro applications. These patents also disclose utilizing optical fiber strands to
provide imaging, as well as performing a chemical analysis of the fluid sample.
In particular, because the sensor is made of optical fibers, the sensor permits the
direct imaging and viewing of the area in which the sensor is placed. The
capability of the sensor to provide imaging and chemical analysis would allow
one to use a single sensor in an in vivo application, such as angioplasty, to be
able to see where the fiber is traveling to deliver the therapeutic treatment, to
use the fiber to deliver the therapeutic treatment, and to concurrently measure
the efficacy of the treatment. One disadvantage of the Walt et al. patents is that they require a
sufficiently large optical energy source to adequately transmit the optical signal
through the optical fiber. In particular, the Walt et al. patents disclose the use of
fluorescent markers to detect, which require high incident excitation energy to
cause the fluorescence. The use of fluorescent markers is the primary reason
for the requirement of a large energy source. Because of this large energy
requirement, the required signal-to-noise ratio to distinguish an appropriate
signal increases, thereby making this approach systemically less effective. In
addition, the Walt et al. patents disclose small beads or dyes, and thus there is
only a small amount of material to react such that the reactant signal is small.
Moreover, if optical filters are not utilized to differentiate the return signal from
the excitation signal, the signal-to-noise ratio further increases.
Another disadvantage is, because of the use of optical fibers, the sensing
device cannot be contained long term within a host body of interest. Instead,
because of the use of optical fibers, the fibers and any other needed wires and
tubes must come out of the host body to needed equipment that is located
outside the host body. For example, the light source and the external image
processing device, i.e., the detector or camera, are located at the far or remote
end of the optical fibers, outside of the host body. In this manner, the Walt et al.
patents require the optical fibers, wires, and tubes to stick out of the host body, and does not allow for a contained assembly to be inserted into a host body.
Furthermore, an additional disadvantage of the optical fibers is that there
currently is no mechanism by which one can prevent the beads from becoming
dislodged from the optical fiber end.
A method of rapid sample analysis for use in the diagnostic microbiology
field is also desirable. The techniques now used for rapid microbiology
diagnostics detect an array of various analytes ranging from antibodies,
antigens, nucleic acids, enzymes, or metabolites. The most popular of these
methods employs antigen-antibody binding. Direct assays involve rapid antigen
testing which is based upon the use of antibodies to recognize and bind to either
whole organisms, particulate, or byproducts thereof. Inherent to this approach is
the need to obtain and characterize the binding of the antibody to unique
structures (e.g., epitopes) on the organism, antigen or analyte being tested. This
process involves the introduction, identification and isolation of the appropriate
antigen-antibody binding pairs and is time consuming. Current diagnostic assays
employing these techniques are therefore limited to conducting only a handful of
diagnostic assays per testing module in order to avoid interference effects and
cross reactions. Moreover, due to the multiple reagent mixing, dispensing, and
signaling steps involved in these traditional schemes, there is limited opportunity
to conduct simultaneous analysis of multiple antigen-antibody binding events. The response time of antibody-antigen reactions in traditional diagnostic
tests of this type ranges from 10 to 120 minutes, and often involves additional
reaction preparation time, depending on the method of detection. The simplest
methods are generally agglutination reactions (e.g., blood typing), but these
methods are less sensitive and provide limited information due to difficulties in
visual interpretation of the reactions. Approaches with slower reaction times
include antigen recognition by antibody conjugated to either an enzyme or
chromosphere. These test types tend to be more sensitive, especially when
spectrophotometric methods are used to determine if an antigen-antibody
reaction has occurred.
Second, with respect to diagnostic testing with nucleic acids, one
approach uses hybridization to unique regions of the target organism. These
techniques require fewer organisms than antigen-antibody binding schemes, but
have longer response times, of up to five hours to complete. The most recent
improvement in the detection of microorganisms has been the use of nucleic acid
amplification. Nucleic acid amplification tests have been developed that
generate both qualitative and quantitative data. However, the current limitations
of these testing methods are related to delays caused by specimen preparation,
amplification, and detection. Currently, the standard assays require about five
hours to complete. The ability to complete much faster detection for a variety of microorganisms would be of tremendous value in a wide range of commercial,
medical, and safety applications.
It is therefore desirable that new sensors capable of discriminating
different analytes, toxins, metabolic by-products, and/or bacteria in cellular or
biological material or in biological exhaust products be developed for medical
diagnostic, environmental, health and safety, remote sensing, military,
food/beverage, and chemical processing applications. It is further desired that
the sensors be adaptable to the simultaneous detection of a variety of analytes
to improve throughput during various chemical and biological analytical
procedures. In the case of medical diagnostic applications, it is further desirable
that the sensors provide real-time or near real-time feedback to facilitate
appropriate diagnostic decisions.
The field of medical diagnostics is evolving rapidly, supported primarily by
the advancing technological revolution. Aided in part by innovations in the
personal electronics and computer markets, devices are constantly being
reconfigured and miniaturized and, at the same time, are capable of increasingly
intricate functions. This trend is echoed in the field of medicine as patients are
demanding similar technological amenities and subsequently raising the
accepted standard of care. Several recent innovations, such as the open
Magnetic Resonance Imaging (MRI) and "keyhole" Coronary Artery Bypass Graft (CABG), are evidence of this growing sentiment.
Testing procedures have also been altered in order to accommodate the
minimally invasive testing protocols that patients desire. Patients are no longer
tolerant of long, laborious diagnostic procedures and shy away from
unnecessary sampling or highly invasive procedures. Several emerging
technologies, such as electronic chemical/biochemical sensors (including
electronic tongues and electronic noses), are especially suited to help meet the
needs of this rapidly changing environment. Indeed, these technologies are the
epitome of avante garde in the field of medical diagnostics because this
equipment may be constructed to be compact, multi-task oriented, minimally
invasive, cost efficient, and disposable.
SUMMARY OF THE INVENTION
The present invention is directed to a method of detecting an analyte in a
fluid sample. The method includes the step of analyzing the fluid sample integral
to a region of interest with a proximally located sensor with an integral detector.
The detector may be integral with the sensor by forming the sensor and the
detector in a common structure, by attaching the detector to the sensor or
through an optical path from the sensor to the detector. The optical path is
preferably an optical fiber. The analyzing step includes the step of providing, for the sensor, a
substrate with a plurality of spatially distinct locations. A reactant is associated
with at least one of the plurality of spatially distinct locations. The fluid sample is
interacted with the reactant. A light source comprising one or more portions of
the electromagnetic spectrum is transmitted to the reactant. The detector is then
used to monitor the reactant to detect the analyte.
The present invention may include a plurality of reactants. Each reactant
may be placed at at least one of the plurality of spatially distinct locations, or
more than one reactant may be placed at at least one of the plurality of spatially
distinct locations. In the alternative, the substrate defines a plurality of cavities,
wherein at least one cavity is placed at at least one of the plurality of spatially
distinct locations. Then, each reactant is placed in at least one of the plurality of
cavities, or more than one reactant is placed in at least one of the plurality of
cavities.
The reactant is selected from the group consisting of a sensing particle, a
receptor molecule attached to a sensing particle, a gel or a reactive material.
The sensing particle is selected from the group consisting of functionalized
polymeric beads, metal oxide particles, thin polymer films, metal quantum
particles, semiconductor quantum particles, agarose, ceramic, glass, or any
combination of the foregoing. The receptor molecule is selected from the group consisting of signaling proteins, chemically sensitive dyes, nucleic acid strands,
nucleotide sequences, biological binding agents, antibodies, antigens, organic
metabolites, inorganic metabolites, functional group receptors, or any
combination of the foregoing. The substrate is comprised of glass, plastic,
silicon, resin, polymer, fiber composite, metal, metal alloy, ceramic, or any
combination of the foregoing.
In one embodiment, the reactant is a fluorescent based reactant, and the
light source is selected such that the frequency and wavelength of the light
compliments the excitation band of the selected fluorescent based reactant. In
an alternative embodiment, the reactant is a coiorimetric based reactant, and the
light source is a portion of the electromagnetic spectrum. Thus, the light source
is a white light.
The detector monitors the reactant as the fluid sample engages the
reactant. Spectroscopic changes are caused by the analyte present in the fluid
sample interacting with the reactant.
In another embodiment, the present invention is directed to a method of
analyzing a fluid sample containing one or more analytes in a biological system.
The method includes providing a physical assembly. The physical assembly
includes a sensor, a detector and an illumination source. The sensor includes a
substrate with a plurality of spatially distinct locations. A reactant is associated with at least one of the plurality of spatially distinct locations. The physical
assembly is introduced proximal to a region of interest where a fluid sample is
present. The reactant is interacted with a fluid sample. A light source
comprising a portion of the electromagnetic spectrum is transmitted to the
reactant. The detector is used to monitor the reactant to detect an analyte while
the detector is proximally located to the region where the fluid sample is present.
In a preferred embodiment, the method includes means for retrieving
optical information from within the biological system. Preferably, the means for
retrieving optical information includes a video monitor.
In a preferred embodiment, the method includes drive and interface
electronics connected to the physical assembly, which may be directly or
indirectly connected to the physical assembly. The physical assembly may be a
probe, or may be spheroidal in shape. The detector is used to monitor the
reactant as the fluid sample engages the reactant. The spectroscopic changes
are caused by the analyte present in the fluid sample interacting with the
reactant.
In another embodiment, the present invention is directed to a method of
detecting an analyte in a fluid sample within a biological system including
analyzing the fluid sample while inside the biological system with a sensor and a
detector which is integral with the sensor. The sensor and the integral detector are inserted into the biological system to be proximally located to the fluid
sample in a region of interest. The detector detects the analyte present in the
fluid sample while the detector is proximally located to the fluid sample in the
region of interest.
The biological system may be a mammalian body, such as a human, either
living or dead. In one embodiment, the sensor and the detector are integrated
with a catheter to introduce the sensor and the detector to the region of interest.
The present invention is also directed to a device for detecting an analyte
in a fluid sample integral to a region of interest. The device includes a physical
assembly. The physical assembly includes a sensor, a detector which is integral
to the sensor, and an illumination source. The sensor is comprised of a substrate
having a plurality of spatially distinct locations, at least one of the spatially distinct
locations having a reactant. The physical assembly introduces the detector
proximate to a fluid sample integral to a region of interest to allow the detector to
monitor the reactant while proximally located to the fluid sample.
The detector may be integral with the sensor by forming the sensor and
the detector in a common structure, by attaching the detector to the sensor, or
through an optical path from the sensor to the detector. Preferably, the optical
path is an optical fiber.
The device preferably includes a plurality of reactants, wherein each reactant is placed at at least one of the plurality of spatially distinct locations or
more than one reactant is placed at at least one of the plurality of spatially distinct
locations. In one embodiment, the substrate defines a plurality of cavities,
wherein at least one cavity is placed at at least one of the plurality of spatially
distinct locations. Thus, each reactant is placed in at least one of the plurality of
cavities, or more than one reactant is placed in at least one of the plurality of
cavities.
The reactant is selected from the group consisting of a sensing particle, a
receptor molecule attached to a sensing particle, a gel or a reactive material. The
sensing particle is selected from the group consisting of functionalized polymeric
beads, metal oxide particles, thin polymer films, metal quantum particles,
semiconductor quantum particles, agarose, ceramic, glass, or any combination of
the foregoing. The receptor molecule is selected from the group consisting of
signaling proteins, chemically sensitive dyes, nucleic acid strands, nucleotide
sequences, biological binding agents, antibodies, antigens, organic metabolites,
inorganic metabolites, functional group receptors, or any combination of the
foregoing. The substrate is comprised of glass, plastic, silicon, resin, polymer,
fiber composite, metal, metal alloy, ceramic, or any combination of the foregoing.
In one embodiment, the reactant is a fluorescent based reactant, and the
light source is selected such that the frequency and wavelength of the light compliments the excitation band of the selected fluorescent based reactant. In an
alternative embodiment, the reactant is a coiorimetric based reactant, and the
light source is a portion of the electromagnetic spectrum. Thus, the light source is
a white light.
In a preferred embodiment, the device includes means for retrieving optical
information from within the region of interest, which is preferably a video monitor.
The physical assembly may be a probe, or may be spheroidal in shape. In
one embodiment, the sensor and the detector are integrated with a catheter to
introduce the sensor and the detector to region of interest.
Additional objects and advantages of the invention will be set forth in part
in the description which follows, and in part will be obvious from the description,
or may be learned by practice of the invention. The objects and advantages of
the invention will be realized and attained by means of the elements and
combinations particularly pointed out in the appended claims.
It is to be understood that both the foregoing general description and the
following detailed description are exemplary and explanatory only and are not
restrictive of the invention, as claimed.
The accompanying drawings, which are incorporated in and constitute a
part of this specification, illustrate several embodiments of the invention and
together with the description, serve to explain the principles of the invention. BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 is a perspective view of one embodiment of the present invention
that analyzes a gaseous fluid sample utilizing a video pick-up assembly, and
utilizing drive and interface electronics that are indirectly connected to the
physical assembly;
Figure 2 is a perspective view of one embodiment of the present invention
that analyzes a gaseous fluid sample ufilizing a video pick-up assembly, and
utilizing drive and interface electronics that are directly connected to the physical
assembly;
Figure 3 is a perspective view of one embodiment of the present invention
that analyzes a liquid fluid sample utilizing a video pick-up assembly, and utilizing
drive and interface electronics that are indirectly connected to the physical
assembly;
Figure 4 is a perspective view of one embodiment of the present invention
that analyzes a liquid fluid sample utilizing a video pick-up assembly, and utilizing
drive and interface electronics that are directly connected to the physical
assembly;
Figure 5 is perspective view of one embodiment of the sensor of the
present invention; and
Figure 6 is a side view of the sensor shown in Figure 5, with a detector and illumination source.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
Reference will now be made in detail to the present preferred
embodiments of the invention, examples of which are illustrated in the
accompanying drawings.
The present invention is directed to method and system for analysis of a
fluid that contains one or more analytes in a system of interest. A system of
interest may include a wide variety of materials. These materials include all types
of biological systems including, but not limited to, medical, animal, environmental
and agricultural applications. Thus, the body of interest may be an animal (e.g.,
mammals, such as humans, dogs and cows, and other animals such as fish) or a
plant (e.g., plants, trees, shrubs and the like). In addition, the body of interest
could be a living or deceased animal or plant, and thus includes, but not limited
to, living or deceased animals, mammals, humans, plants, trees and the like. The
body of interest could also be a food product, or the wash of a food product.
The present invention may be used for either gaseous fluids or liquid fluids.
Thus, the present invention may utilize either "electronic nose" or "electronic
tongue" technology, as well as combining features of both technologies. With
respect to sampling gas samples, the present invention may utilize any type of electronic nose sensor, including, but not limited to, conductivity sensors,
piezoelectric sensors, metal oxide silicon field effect transistor (MOSFET) sensing
devices, optical sensors and spectrometry-based sensing methods. In addition,
with respect to sampling liquid samples, the present invention may utilize any type
of electronic tongue sensor, including, but not limited to, those based on "DNA on
a chip" technology; those based on thin films, dyes or beads that act as receptor
units; probe arrays; conducting polymer gas sensors; acoustic wave gas sensors;
field-effect gas sensors; electrochemical gas sensors; pellistors; fiber optic gas
sensors; discotic liquid crystals; and pulse spectroscopy cells. Again, the present
invention is configured to allow one to combine a type of electronic tongue sensor
with a type of an electronic nose sensor to allow one to sample both liquids and
gases simultaneously.
Depending on the type of sensor utilized, the detector includes, but is not
limited to, optical detectors, such as, for example, complementary metal oxide
semiconductor (CMOS) detectors, photovoltaic cells, amorphous silicon photo¬
sensor on glass (e.g., photodiode or TFT based), Organic Light Emitting Diode
(OLED) detectors, infrared detectors, fluorescent detectors, ultraviolet detectors
or charge coupled device (CCD) detectors.
The device of the present invention is suitably configured such that the
detector is integral with the sensor in a common structure. In this manner, the actual detection of analytes takes place while the sensor and detector are
proximally located to the fluid sample, when the fluid sample is integral with its
system or body of interest. There are a variety of manners in which the sensor
and detector may be integral with each other. For example, the sensor and
detector may be formed in a common structure, such as, for example, in the same
mold or die. In addition, the detector may be attached to the sensor through any
number of attachment mechanisms, including, but not limited to, the use of
adhesives or fastening devices. Also, the detector may be situated near the
sensor, but not be part of the same mold of the sensor nor be attached to the
sensor. In this situation, an optical light path from the sensor could be transmitted
to the detector from the sensor through a variety of mechanisms, including, but
not limited to, an optical fiber. In one embodiment, the detector is situated below
the sensor such that light from the sensor is transmitted to the detector.
The method and system of the present invention includes a sensor which
is preferably comprised of a substrate having a plurality of spatially distinct
locations, at least one of the spatially distinct locations having a reactant. The
substrate is any material capable of having a reactant incorporated therewith.
There are a variety of manners in which the reactant may be incorporated with
the substrate. In one embodiment, the reactant is attached to the substrate. In
another embodiment, the reactant is intercalated within the substrate. Preferably, there is a plurality of reactants, each reactant being placed at one of the spafially
distinct locafions. In the alternative, more than one reactant may be placed at
one of the plurality of spatially distinct locations. In a preferred embodiment, the
substrate defines a plurality of cavities, with at least one cavity being positioned at
at least one of the spatially distinct locations. Thus, in this embodiment, one
reactant may be placed in at least one of the cavities or, in the alternative, more
than one reactant may be placed in one of the cavities. The spatially distinct
locations are comprised of locations spaced apart from one another on the
substrate. These locations may be in an ordered array or may be unordered.
The reactant is any material capable of interacting with an analyte that
experiences changes that are detectable and that are indicative of the analyte
present. The reactant may be a sensing particle, a receptor molecule attached to
a sensing particle, a gel, or a reactive coating.
The method of analyzing a fluid sample for an analyte of interest includes
having a sensor preferably comprised of a substrate having a plurality of spatially
distinct locations, wherein a reactant is associated with at least one of the plurality
of spatially distinct locations. To detect the analyte, the fluid sample is interacted
with the reactant, and a light source comprising a portion of the electromagnetic
spectrum is transmitted to the reactant. Because of the interaction between the
analyte and the reactant, the reactant will absorb electromagnetic radiation at one or more frequencies. The detector is used to monitor the reactant to sense
changes in absorbed electromagnetic radiation, and thus spectroscopically detect
the analyte.
Uses of the Present Invention
The present invention may be utilized in a wide variety of applications to
perform localized assays in specific regions of interest. In particular, the present
invention is configured to be able to be placed in the specific region of interest,
and is able to perform detection of analytes in a sample at the region of interest
while proximally spaced in the region of interest.
For human and animal applications, the present invention may be utilized
to determine a variety of local biochemical or chemical conditions that can be
used to indicate or diagnose specific local or systemic disorders or states. For
example, the present invention may be used to isolate the presence of specific
biochemical "markers," such as cardiac or tumor markers, contained with
biological serum or at a tissue junction. As such, it may prove useful in
researching causal or predictive links between specific markers and known health
states, such as unstable angina. As another example, the present invention may
also prove useful for discriminating between different internal deposits, such as,
for example, lipid laden plaque versus other plaques inside cardiac arterial walls, thereby providing clinicians with diagnostic data that can help determine patient
health states.
The present invention will be capable of performing a multitude of varying
forms of analyses and is particularly well suited for minimally invasive diagnostics
protocols requiring real-time site-directed feedback data. Unlike existing
diagnostic equipment, the present invention requires minimal sample volume and
processing, and thus is able to operate in what previously were inaccessible or
inoperable mediums. Miniaturized platform size and a high degree of integration
allow placement of the system into several existing medical applications. A
variety of minimally invasive diagnostic protocols involving catheter placement
exist currently that allow real-time monitoring of parameters, such as, for
example, intra-arterial pressures and pH. However, no technology currently
exists that allows an extensive panel of real-time analysis to be conducted
concurrent with minimally invasive procedures.
There are three main areas where the present invention would provide
great improvement in current medical diagnostic capabilities. The first involves
continuous monitoring of critical care (ICU) patients. These patients, generally
suffering in some aspect from a deregulation of homeostasis, often need to have
simple blood chemistries, such as, for example, electrolytes and blood gases,
drawn on a rigorous hourly basis. For example, the treatment for a patient admitted in Diabetic Keto-Acidosis consists almost entirely of correcting fluid
electrolytes while stabilizing blood glucose levels. This is often an arduous task
that, in some circumstances, amounts to "chasing your tail" as corrections in
treatment are dependent upon the results of the hourly blood draws. The present
invention would provide one the ability to monitor, in real-time, electrolytes, blood
glucose, ketones and blood gas parameters, and thus would enable the physician
to more efficiently tailor the patient's regimen. Optionally, this could be
accomplished through the integration of the chemical/biochemical sensor into a
typical catheter that is used to provide central venous access for hydration.
Several other examples exist in which real-time monitoring would provide a
distinct advantage in the acute care setting. Poly-trauma patients, often afflicted
with similar hemostatic challenges, could also benefit greatly from such diagnostic
integration. Moreover, patients admitted for suspected bacterial sepsis could be
monitored for the development of complications such as Disseminated
Intravascular Coagulopathy (DIC), a commonly fatal state. In this situation, the
present invention could monitor parameters associated with developing a
Coagulopathy, such as fibrinogen and fibrin split products, could simultaneously
help characterize the offending bacterial agent, and thus help determine the
appropriate anti-microbial therapy.
The second area in which the present invention would provide great improvement in current medical diagnostic capabilities is with its integration with
new generation endoscopic and laparoscopic technologies. There are many new
technologies, both therapeutic and diagnostic, that involve minimally invasive
procedures. On a daily basis, endoscopes are utilized in the field of medicine to
survey a variety of things such as, for example, gastric ulcers, tumors, colon
polyps, and tissue abnormalities. However, little information other than visual
cues is provided to the physician to make their clinical assessment. Quite often,
the physician is put in the position of taking a conservative approach and either
removing or taking a biopsy of a potential malignant or atypical appearing entity.
Many of these procedures, as is learned from subsequent pathology reports, are
unnecessary and could have been avoided had the proper information been
provided. For example, if a physician performing an endoscopic procedure to
survey a patient's gastric ulcer was able to detect the presence of the bacteria
Helicobacter pylori, he or she may be able to avoid an unnecessary biopsy for
possible malignancy by detecting this ulcer causing bacteria.
Similar guidance of therapeutic decisions could be provided in a concurrent
fashion in the use of bronchoscopy. Frequently, bronchoscopy is utilized to
sample inaccessible fluids or organisms present in the lungs. By using the
present invention, a physician would be able to both visualize an area of interest
and simultaneously sample the local environment looking for specific bacterial metabolites or fluid characterization.
Comparable uses for this technology may also be seen in the use of
colonoscopy. Colonoscopy is characteristically used to survey anatomical
aberrations such as, for example, neoplasms and polyps and local area of
inflammation in the intestinal tract. Through the incorporation of tumor marker
agents such as carcino-embryonic antigen (CEA) for colon cancer and local
cytokines for indicators of specific inflammatory diseases such as, for example,
Crohns or Ulcerative Colitis, the clinician may be able to enhance his or her
diagnostic ability and survey more intensely for specific etiologic agents of
disease.
The third area in which the present invention would provide great
improvement in current medical diagnostics is in surgical intervention and
bioengineering. The field of surgery, predicated upon its distinct ability to be
invasive yet beneficial, has perhaps made the greatest leap to the realm of
minimally invasive diagnostic and therapeutic techniques. With the advent of the
laparoscope and the accompanying surgical tools, surgeons are now able to
perform a majority of their procedures through minute incisions. Although this is
obviously a desirable shift for the patient, it has provided a technical challenge
and has limited, in some aspects, the surgeon's ability to completely visualize the
procedure. Intricate fiberoptic laparoscope with illumination sources linked to viewing
monitors are commonplace in every operating room. However, there are still
inaccessible regions that were previously accessible in the more open invasive
approaches. The present invention could provide information regarding the
viability of tissues by sensing necrosis, thrombosis, decreased perfusion, and
local inflammation and local tissue metabolites. With this information, a surgeon
would be able to custom tailor his or her procedure around specific biochemical
thresholds indicative of disease or anatomical aberration.
For example, a patient undergoing an aortic arch vascular repair often has
blood flow diverted from organs such as his or her kidney and colon. Continuous
monitoring of local metabolites indicative of stress such as, for example, lactic
acid or cellular breakdown components, would provide the surgeon with specific
information regarding the viability of bypassed organs. In the case of open heart
surgery, a real-time intra-cardiac monitoring of enzymes associated with
myocardial infarction, such as, for example, CK-MB, would help eliminate "silent
heart attacks" that occur during such procedures. This type of technology would
not only give the added advantage of providing real-time data feedback but would
also allow specific localized surveys of anatomical regions to be conducted, and
thus serve as an extension of the surgeon's diagnostic acumen.
In addition to medicine, the present invention may be utilized in food safety applications. In particular, the present invention could be utilized to detect
pesticides, hormones, toxins, antibiotics, bacterial contamination, and levels of
lipid, sugar and oil. Recently, studies have shown an alarming incident of
pesticides and hormones in produce purchased in supermarkets. Following up
on a 1993 National Academy of Sciences study critiquing federal pesticides
standards relating to protection of infants, the Environmental Working Group
(EWG) commissioned laboratory tests of baby food made by industry leaders. It
found 16 pesticides, including three carcinogens, five 'possible' carcinogens, eight
neurotoxins, five endocrine disruptors, and five 'toxicity one' chemicals.
Because of the widespread industry of use of recombinant bovine growth
hormone (rBGH) to boost milk production, most dairy cows suffer from clinical
mastitis, a common infection of the udder. The antibiotics used to treat these
cows often finds its way into our milk. The present invention may be used to
sample a wash from fruits, grains or other produce, or to directly sample a
solution made from these. Alternatively, the present invention may be used to
test liquid food products, such as milk, for example, to monitor for pesticides,
bacterial presence, hormones, antibiotics, rodent feces, or specific fungal toxins,
such as afaltoxin. Still further, the present invention may be used in ruminant
protein screening, for example, to screen for bovine albumin and ovine albumin,
which could help document compliance to prevent Bovine Spongiform Encephalopathy (BSE), also known as "mad cow" disease, as well as to detect
other residues.
There is also growing concern regarding the accelerating use of genetically
modified crops and their purity. There is evidence that in certain cases
genetically modified crops actually concentrate toxins, or in some cases, express
proteins whose metabolic breakdown products are toxic to the person or animal
that consumes the crop. The present invention could be used to monitor for
specific toxins, proteins, and even for specifically coded DNA sequences to
ensure crop safety.
Food safety is an ever present concern in meat processing operations as
well. Bacterial contamination is a significant health risk that is often caught after
meat processing and distribution has already occurred. Because of its unique
capability to detect specific bacteria, the present invention could innovate the
meat processing industry by providing immediate feedback regarding the
presence of specific bacterial contamination, either directly at the surface of the
meat or in meat wash products. As well, the present invention could be used to
monitor for a wide range of residues, including, but not limited to, toxins,
pesticides, hormones, antibiotics, specific fungal toxins (such as aflatoxin), and
the like.
Food grading is another area where the present invention would be of use. This system can be used in meats to detect lipid levels and other factors that
correlate directly with "eatability." In crops, the same techniques can be used to
detect factors such as, for example, specific oil and sugar levels.
Embodiments of the Present Invention
The present invention is able to detect both an individual analyte and
mixtures of analytes. Preferably, the present invention includes a plurality of
reactants that may simultaneously detect many kinds of analytes rapidly. In
addition, the present invention may be either reusable, assuming the reactants
can be returned to their original state after use, or replaceable, if the relevant
chemistry is not reversible or if dictated by reasons of hygiene or other issues of
convenience and/or expense.
Figures 1 and 2 illustrate embodiments of a system of the present
invention for detecting analytes in an air fluid sample. Such a system can be
used to detect gas-born analytes, including, but not limited to, metabolic
byproducts in bodily structures such as the esophagus, the gastrointestinal tract
or the abdominal cavity.
As shown in Figures 1 and 2, the system 100 includes a sensor structure
101 , a physical assembly 102 for proximally placing the sensor in a region of
interest, and drive and interface electronics 103. The drive and interface WO 00/68670 PCT/USOO/l 2409
electronics may be connected either indirectly (Figure 1) or directly (Figure 2) to
the physical assembly 102. In a preferred embodiment, the system 100 includes
video pick-up assembly 104. Figures 3 and 4 illustrate embodiments of a
system 110 of the present invention for detecting analytes in a liquid fluid sample.
Such a system may be ufilized to detect liquid-born analytes, including, but not
limited to, detecting cardiac or tumor markers within biological serum; detecting
different types of plaque within cardiac arterial walls; detecting electrolytes,
ketones, blood glucose, and blood gas parameters in blood samples; detecting
bacteria in a sample, such as a fluid sample in a gastric ulcer or lungs; detecting
bacteria, pesticides, hormones, antibiotic and the like in wash from fruits, grains,
or other products, or from liquid food products, such as, for example, milk, juices,
canned soups and breakfast drinks; for environmental monitoring, including
testing runoff water, ponds, lakes, rivers, wells, mining operations and testing
toxins on a farm, in both soil and water; and for monitoring plants.
As shown in Figures 3 and 4, the system 110 includes a sensor structure
111 , a detector 112, an illuminafion source 113, a physical assembly 114 for
proximally placing the sensor in a region of interest, and drive and interface
electronics 115. The sensor 111 , the detector 112 and the illumination source
113 are all connected to the physical assembly 114 in some fashion. For
example, either the sensor 111 , the detector 112 and/or the illumination source 113 may be formed in a common structure with the physical assembly 114, such
as, for example, in the same mold or die. In addition, either the sensor 111 , the
detector 112 and/or the illumination source 113 may be attached to the physical
assembly 114 through any number of attachment mechanisms, including, but not
limited to, the use of adhesives or fastening devices.
The drive and interface electronics 115 are connected either indirectly
(Figure 3) or directly (Figure 4) to the physical assembly 114. In this embodiment,
the detector 112 is positioned below the sensor structure 111 to allow for data
acquisition. In a preferred embodiment, the system 110 includes video pick-up
assembly 117. In another preferred embodiment, for fluorescent measurements,
the system 110 includes a filter assembly 116 that removes the excitation
wavelength.
Although any number of types of sensors may be utilized for the sampling
of the fluid of interest, a preferred sensor structure is based on utilizing a sensor
including at least one reactant. In particular, after the reactant interacts with the
analyte of interest in the fluid sample, the reactant experiences spectroscopic
changes that may be detected using a suitable detector. This preferred sensor
structure is discussed in detail in the following U.S. Applications for Patent: Ser.
Nos. 60/093,111 , 09/354,882, 60/144,436, 60/144,435, 60/144,126 and
PCT/US99/16162, all filed on 16 July 1999; Ser. No. 09/287,248 filed 7 April 1999; Ser. Nos. 60/179,369, 60/179,424, 60/179,294, 60/179,380, 60/179,380,
60/179,292 and 60/179,293, all filed on 31 January 2000; the foregoing all owned
by the University of Texas and subject to license by Applicants; and Ser. No.
60/133,230, filed 7 May 1999, jointly owned by Applicants and the University of
Texas, each of which is herein incorporated by reference in its entirely.
In one embodiment, the reactant is a plurality of chemically sensitive
structures that produce a detectable signal in the presence of an analyte.
Preferably, the reactants produce coiorimetric or fluorescence signals upon
exposure to an analyte. In a preferred embodiment, the sensor structure includes
an array of such reactants.
Examples of the reactants include, but are not limited to, functionalized
polymeric beads (e.g., polystyrene-polyethylene-giycol (PS-PEG) resin beads),
gels, metal oxides particles (e.g., silicon dioxide [SiO2] or aluminum oxides
[AI2O3]), thin polymer films, metal quantum particles (e.g., silver, gold, platinum,
etc.), semiconductor quantum particles (e.g., Si, Ge, GaAs, etc.), agarose,
ceramics, glass, or any combination of the foregoing. The particular reactant
selected is dependent on its specific wettability characteristics, porosity, and
reflectivity. In this manner, the reactant selected will be ideally suited to detect
the particular analyte desired to be detected.
In one embodiment, the reactant is a sensing particle, such as, for example, PS-PEG resin beads. The choice of a PS-PEG matrix is based on its
wettability by aqueous solutions and the availability of well developed literature
methods for its derivatization as described in the experimental section.
In one embodiment, the reactant is a receptor molecule synthesized,
adsorbed onto, attached to, or intercalated into a sensing particle. The particular
receptor molecule chosen depends on which analyte one wants to detect.
Examples of chemically active receptor molecules that may be formed on the
surface of the sensing particle include a wide variety of molecules, including, but
not limited to, signaling proteins (e.g., antigens, antibodies, and enzymes),
chemically sensitive dyes, nucleic acid strands, nucleotide sequences, biological
binding agents (e.g., avidin/biotin, lectins, and chelators), organic/inorganic
metabolites, and functional group receptors.
In one embodiment, the sensing particles have diameters in the range of 1
- 500 microns and may actually change size (e.g., swell or shrink) when exposed
to analytes in the fluid sample. For example, a fluid sample that includes a large
amount of lipid material may cause non-polar particles to change in volume when
the particles are exposed to such a fluid.
As discussed above, the sensor includes a substrate having a plurality of
spatially distinct locations, with at least one of the plurality of spatially distinct
locations having a reactant. In one embodiment, as shown in Figures 5 and 6, the substrate is a support member 120 configured to include the reactants. The
support member 120 is preferably used to localize the reactants, as well as to
serve as a microenvironment in which chemical assays may be performed. The
support member 120 is preferably made of any material capable of supporting the
reactants, while allowing the passage of the appropriate wavelength of light.
Preferably, the support member 120 is also made of a material substantially
impervious to the fluid sample of interest. The support member 120 may be
made of a variety of materials, including, but not limited to, silicon, plastics, glass,
metals, resins, polymers, fiber composites, metals, metal alloys, ceramics or any
combination of the foregoing.
As shown in Figures 5 and 6, the support member 120 preferably includes
a plurality of cavities 130. In one embodiment, the cavities 130 are formed such
that at least one particle 124 is substantially contained within a cavity 130. In an
alternative embodiment, a plurality of particles are contained within a single cavity
(not shown). A detailed description of the formation of cavities in a support
member is discussed, for example, in U.S. Application Serial Nos. 90/287,248,
filed April 7, 1999; 60/144,436, filed July 16, 1999; and 60/179,369, field January
31 , 2000; each of which is subject to joint license by Applicants, and are herein
incorporated by reference thereto.
As stated above, in addition to the sensor structure 111 , the system 110 includes a detector 112 and an illumination source 113. As shown in Figure 5,
light comprising a portion of the electromagnetic spectrum, which originates from
the illumination source 113, preferably passes through the sensor structure or
array 111 and is modulated by the reactants of the sensor structure, before
impinging on the proximally spaced detector 112. For fluorescent based systems,
the light source 113 is a wavelength tailored and preferably filtered source, such
as a light emitting diode (LED), whose frequency and wavelength output is
chosen to compliment the excitation band of the chosen sensing fluorophore
particle. For example, in one embodiment, a high intensity blue LED is
appropriate complement to fluorescein. For coiorimetric (e.g., absorbance) based
systems, the light source 113 is preferably a "white" light. In one embodiment,
the light is delivered proximate to the sensor through a fiber optic assembly (not
shown).
Monitoring the spectroscopic changes to the reactants is preferably
accomplished by use of the detector 112 itself and may be assisted by a
microprocessor (such as microprocessor 140 shown in Figure 6) (or other optical
or electronic processing system components) coupled, directly or indirectly, to the
detector 112.
The detector 112 measures changes in the optical characteristics which
occur upon the interaction of the reactants with the analytes. A wide range of optical detectors, including, but not limited to, charged coupled detectors (CCD),
ultraviolet detectors or fluorescent detectors, may be used. For fluorescence
measurements, as shown in Figure 6, a band limiting or band pass optical filter
116 may be placed between the support member and detector 112 to remove the
excitation wavelength.
The system 110 of the present invention includes a sensor structure 111
with an integral detector 112 to allow the detection of any analyte to occur within
the region of interest. The physical assembly 114 is used to place the sensor
structure 111 and the detector 112 within the region of interest. In human or
animal applications, to place the sensor structure 111 and the detector 112 in the
region of interest, the physical assembly 114 is configured to be inserted through
an opening in the biological system, such as, for example, an existing orifice or
incision, to locate the physical assembly 114 (with sensor and detector) proximate
to the region of interest. In one embodiment, the sensor structure 111 and the
detector 112 are integrated into a typical catheter that is used to provide central
venous access for hydration.
Because the present invention may be used in in vivo or in vitro
applications, there are engineering constraints that must be observed in order to
make the present invention compatible with the body. In particular, the physical
assembly 114 must be of a shape and size that permits it to be delivered proximate to the region of interest with minimal invasive effects, typically requiring
the overall diameter to be 15 mm or less. In addition, the physical assembly 114
should be smooth, must be constructed of bio-compatible materials, and must
operate at safe energy levels and temperatures. In one embodiment, the physical
assembly 114 has the shape of a probe. In another embodiment, the physical
assembly 114 is spheroidal in shape.
In addition to the sensor structure 111 , detector 112, illumination source
113, and the physical assembly 114, the system 110 includes drive and interface
electronics 115. In one embodiment, as shown in Figure 3, the drive and
interface electronics 115 are indirectly connected to the physical assembly 114.
The indirect connection of the drive and interface electronics 115 with the
physical assembly may include, but is not limited to, utilizing wires. One of skill in
the art can also readily recognize that alternative indirection connections include,
but are not limited to, utilizing induction methods, such as using radio waves,
microwaves, or infrared sensing. In an alternative embodiment, as shown in
Figure 4, the drive and interface electronics 115 are directly connected to the
physical assembly 114. In one embodiment, the drive and interface electronics
115 are attached to one end of the physical assembly 114.
The drive and interface electronics 115 include, but are not limited to, well
known electrical components such as, for example, a microprocessor to acquire data and to manipulate the data, memory chips to store the data, timing circuitry,
calibration circuitry, communication interface circuitry, provisions to handle
applicable device triggering and the like. These types of electrical components
are well known in the electrical arts, and a detailed discussion of each is beyond
the scope of this invention.
In a preferred embodiment, the present invention includes means for
retrieving optical information from within the body of interest. In particular, the
present invention preferably includes optical video technology that acquires and
permits the display of imagery from within the body of interest that can be used to
visualize and inspect the areas of interest, as well as performing localized
chemical/biochemical assays. In particular, as shown in Figures 1 through 4,
video pick-up assembly 104 or 117 allows one to view the area where the
physical assembly 102 or 114 is being positioned. The video pick-up assembly
104 or 117 is preferably a video monitoring system to allow one to view the region
of interest as the physical assembly 102 or 114 is being inserted to the region of
interest.
Optical Systems
Presently, optical sensors may be based upon coiorimetric or fluorescent
based systems. For either system, the sensor is generally made up of reactants which experience spectroscopic changes after interacting with an analyte of
interest. In addition, for either system, a detector is utilized to detect the
spectroscopic changes experienced by the reactants.
Coiorimetric Based Systems
Evaluation of the changes in optical properties of the various reactants in a
coiorimetric based system may be accomplished in the following fashion. Light is
delivered to the sensor structure and the detector records the coiorimetric
changes in the light that passes through the reactants. A commercial-grade 24-
bit (8 bit x 3 color planes) video camera (not shown) is preferably used to detect
the reactant changes, providing the ability to acquire images at a rate of
approximately 30 times per second. This speed is valuable in the initial kinetic
characterization of reactants, such as, for example, micro-sphere sensors.
Although not discussed at length here, evaluation of the transient data could
provide an additional means to identify the chemical composition of these
samples. It should be emphasized that the rapid acquisition of time dependent
coiorimetric data provides a particularly powerful analytical capacity when these
capabilities are combined with modem pattern recognition algorithms.
For coiorimetric based systems, the spectral information is acquired from
the detector in a format where the white light has been simplified, for instance, by assigning relative intensity values to three key wavelength regions, namely red-
green-blue (RGB). This interpretation has been adopted from standard color
wheel analysis protocols and represents one Commission Internationale de
L'Eclairage (CIE) standard color space that can be used for coiorimetric
processing. The linear intensity levels recorded with the detector are normalized
against an averaged background light level transmitted through particles which
are underivatized. The level of the averaged background light level through
underivatized particles is taken as 100% transmittance. In a reactant particle-
based system, it should be noted, however, that transmission intensities recorded
through a particle are typically 20% less than those obtained in the absence of
the particle, as expected since unavoidable light scattering occurs. For this
reason, underivatized particles in the cavities are used as reference cells instead
of empty cavities.
Absorptance (AR G,B) values reported for each of the three RGB hues are
determined from the following equation:
Figure imgf000050_0001
where TR G B is defined at the transmitted intensity through a particle in a particular
environment for each of the selected hues, and T0 is the average background
intensity through the underivatized particles. The coherent appearance of color through the center of the particle indicates that the analyte is incorporated
uniformly throughout the particle. Collectively, these results demonstrate that
aqueous analytes can penetrate into the polymer particles, that the particles are
suitable media for optical measurements, and that the detector can be used to
quantify the coiorimetric changes. Other systems may be used wherein the light
source and the sensor operating frequency and wavelength include the receptor
activation range. The term "receptor activation range" is thus understood herein
to refer to that portion of the electromagnetic spectrum in which the receptor
absorbs or interacts with electromagnetic radiation.
Fluorescent Based Systems
Fluorescent based diagnostic assays operate under the same general
principles, although they differ in the optical excitation and signal output
methodology. In a particle-based reactant system, the actual receptor molecule
design and attachment to the sensing particle is identical to coiorimetric
techniques. In the fluorescent mode, the reactant emits a fluorescent rather than
a coiorimetric signal. This is accomplished through the conjugation of chemically
sensitive fluorophores to both the particle substrate and the custom designed
receptor compounds. These fluorophores, responding to local binding events in
and around the particle, emit a unique fluorescent signature. However, this requires excitation via a specific wavelength of light, either through the use of
optical filters or specifically tuned excitation sources such as light emitting diodes
(LED). In particular instances, fluorescent signaling schemes are employed to
amplify signal output from otherwise indetectable analytes. Signal detection is
still accomplished using an optical detector such as, for example, a CCD detector.
This information is then processed and both qualitative and quantitative values
are achieved using correlations with the intensity of the specific wavelength of
light emitted from the reactants. In this scenario, signal analysis is simplified due
in part to the narrow spectral signal input.
Example of Optical Detection Based on o-cresolphthalein
Complexone Derivatized Micro-spheres Utilizing Coiorimetric Based
System
The following is an illustrative example showing how a particle reactant can
acquire information related to the local chemistry of fluids based on a coiorimetric
based system. The information is obtained from optical photomicrographs that
were taken of o-cresolphthalein complexone derivatized particles or micro-
spheres. Upon the exposure of the particles to aqueous solutions containing no
Ca+2 and 0.1 M Ca+2, these micro-spheres change color in a dramatic manner.
Indeed, the micro-spheres are virtually transparent across the entire visible region
when no Ca+2 is present in the solution. In contrast, the same micro-sphere
exposed to 0.1 M Ca+2 displays a markedly different physical appearance as indicated by purple hue. The UV-vis absorbance spectrum reveals the absorption
band is centered at = 550 nm which approximately matches the solution
absorbance spectrum of o-cresolphthalein complexone responding to Ca+2.
The sensor structure of the electronic tongue sensor as described herein
has the capacity to simultaneously analyze the chemical composition of complex
mixtures of analytes. In particular, the composite changes to different analytes
were analyzed for four different environments including no analyte, 0.1 M Ca+2,
0.1 M Ce+3, a mixture of 0.1 M Ca+2 and 0.1 M Ce+3 for four different micro-
spheres. The four different micro-spheres were tagged with: (1) underivatized, (2)
o-cresolphthalein complexone, (3) alizarin complexone, and (4) fluorescein. For
each of the environments on each of the sensors, five representative pH's
(3,5,7,9, and 11), all buffered by a mixture of 0.04 M phosphate, 0.04 M acetate,
and 0.04 M borate, were evaluated.
Quantification of coiorimetric changes using the RGB analysis were
compiled for each of four chemically functionalized micro-spheres. This protocol
conforms to the capabilities afforded by commercially available CCD-based
detectors. With the use of the CCD detector, three channels of data are available
for each micro-sphere as a function of time. In fact, since the micro-sphere is
significantly larger than the associated CCD pixels, redundant information is
available allowing for a signal averaging to be made for each micro-sphere. For the underivatized micro-sphere, little light attenuation is observed for
all of the studied cases. A small deviation in the signals recorded for this micro-
sphere suggests minor alterations in the light scattering changes in the
absorbance properties or differences in the alignment occurred. In any event, the
differences are relatively small when compared to the other micro-sphere
structures. In fact, each type of micro-sphere displays spectral features and
chemical selectivity vastly different from the other ones. For example, the o-
cresolphthalien micro-spheres display significant color attenuation only in the two
cases at pH = 11 with Ca+2 alone and Ca+2/Ce+3 mixtures. In particular, in these
situations, most significant attenuation occurs in green wavelengths, along with
modest color attenuation in red wavelengths. In all other chemical environments,
the color attenuation is less significant.
Other embodiments of the invention will be apparent to those skilled in the
art from consideration of the specification and practice of the invention disclosed
herein. It is intended that the specification and examples be considered as
exemplary only, with a true scope and spirit of the invention being indicated by
the following claims.

Claims

WHAT IS CLAIMED IS:
1. A method of detecting an analyte in a fluid sample comprising the
step of analyzing the fluid sample integral to a region of interest with a proximally
located sensor with an integral detector.
2. The method of claim 1 wherein the detector is integral with the
sensor by forming the sensor and the detector in a common structure.
3. The method of claim 1 wherein the detector is integral with the
sensor by attaching the detector to the sensor.
4. The method of claim 1 wherein the detector is integral with the
sensor through an optical path from the sensor to the detector.
5. The method of claim 4 wherein the optical path comprises an optical
fiber.
6. The method of claim 1 wherein the analyzing step comprises the
steps of: providing, for the sensor, a substrate with a plurality of
spatially distinct locations, at least one of the plurality of spatially distinct locations
having a reactant;
interacting the fluid sample with the reactant,
transmitting a light source comprising one or more portions of the
electromagnetic spectrum to the reactant, and
monitoring the reactant to detect the analyte.
7. The method of claim 6 further comprising the step of providing a
plurality of reactants, wherein each reactant is placed at at least one of the
plurality of spatially distinct locations.
8. The method of claim 6 further comprising the step of providing a
plurality of reactants, wherein more than one reactant is placed at at least one of
the plurality of spatially distinct locafions.
9. The method of claim 6 wherein the substrate defines a plurality of
cavities, wherein at least one cavity is placed at at least one of the plurality of
spatially distinct locations.
10. The method of claim 9 further comprising a plurality of reactants,
wherein each reactant is placed in at least one of the plurality of cavities.
11. The method of claim 9 further comprising providing a plurality of
reactants, wherein more than one reactant is placed in at least one of the plurality
of cavities.
12. The method of claim 6 wherein the reactant is selected from the
group consisting of a sensing particle, a receptor molecule attached to a sensing
particle, a gel or a reactive material.
13. The method of claim 12 wherein the sensing particle is selected
from the group consisting of functionalized polymeric beads, metal oxide particles,
thin polymer films, metal quantum particles, semiconductor quantum particles, agarose, ceramic, glass, or any combination of the foregoing.
14. The method of claim 12 wherein the receptor molecule is selected
from the group consisting of signaling proteins, chemically sensitive dyes, nucleic
acid strands, nucleotide sequences, biological binding agents, antibodies,
antigens, organic metabolites, inorganic metabolites, functional group receptors,
or any combination of the foregoing.
15. The method of claim 6 wherein the substrate is comprised of glass,
plastic, silicon, resin, polymer, fiber composite, metal, metal alloy, ceramic, or any
combination of the foregoing.
16. The method of claim 6 wherein the reactant is a fluorescent based
reactant, and the light source is selected such that the frequency and wavelength
of the light compliments the excitation band of the selected fluorescent based
reactant.
17. The method of claim 6 wherein the reactant is a coiorimetric based
reactant, and the light source is a portion of the electromagnetic spectrum.
18. The method of claim 17 wherein the light source is a white light.
19. The method of claim 6 wherein the step of monitoring the reactant
comprises monitoring the spectroscopic changes of the reactant by the detector
as the fluid sample engages the reactant, wherein the spectroscopic changes are
caused by the analyte present in the fluid sample interacting with the reactant.
20. A method of analyzing a fluid sample containing one or more
analytes in a biological system comprising the steps of:
providing a physical assembly, the physical assembly including a
sensor, a detector and an illumination source, the sensor including a substrate
with a plurality of spatially distinct locations, at least one of the plurality of spatially
distinct locations having a reactant;
introducing the physical assembly proximal to a region of interest
where a fluid sample is present;
interacting a fluid sample with the reactant;
transmitting a light source comprising a portion of the
electromagnetic spectrum to the reactant; and
monitoring, utilizing the detector, the reactant to detect an analyte
while the detector is proximally located to the region where the fluid sample is
present.
21. The method of claim 20 further comprising the step of providing
means for retrieving optical information from within the biological system.
22. The method of claim 21 wherein the means for retrieving optical
information comprises a video monitor.
23. The method of claim 20 further comprising the step of providing
drive and interface electronics connected to the physical assembly.
24. The method of claim 23 wherein the drive and interface electronics
are directly connected to the physical assembly.
25. The method of claim 23 wherein the drive and interface electronics
are indirectly connected to the physical assembly.
26. The method of claim 20 wherein said physical assembly is a probe.
27. The method of claim 20 wherein said physical assembly is
spheroidal in shape.
28. The method of claim 20 wherein the step of monitoring the reactant
comprises monitoring the spectroscopic changes of the reactant by the detector
as the fluid sample engages the reactant, wherein the spectroscopic changes are
caused by the analyte present in the fluid sample interacting with the reactant.
29. A method of detecting an analyte in a fluid sample within a
biological system comprising the step of analyzing the fluid sample while inside
the biological system with a sensor and a detector which is integral with the
sensor, wherein the sensor and the integral detector are inserted into the
biological system to be proximally located to the fluid sample in a region of
interest, and the detector detects the analyte present in the fluid sample while the
detector is proximally located to the fluid sample in the region of interest.
30. The method of claim 29 wherein the biological system is a mammalian body, such as a human, either living or dead.
31. The method of claim 30 wherein the sensor and the detector are
integrated with a catheter to introduce the sensor and the detector to the region of
interest.
32. The method of claim 31 wherein the biological system is a
mammalian body, such as a human, either living or dead.
33. A device for detecting an analyte in a fluid sample integral to a
region of interest comprising:
a physical assembly, the physical assembly including a sensor, a
detector which is integral to the sensor, and an illumination source; and
the sensor comprised of a substrate having a plurality of spatially
distinct locations, at least one of the spatially distinct locations having a reactant;
wherein the physical assembly introduces the detector proximate to
a fluid sample integral to a region of interest to allow the detector to monitor the
reactant while proximally located to the fluid sample.
34. The device of claim 33 wherein the detector is integral with the
sensor by forming the sensor and the detector in a common structure.
35. The device of claim 33 wherein the detector is integral with the
sensor by attaching the detector to the sensor.
36. The device of claim 33 wherein the detector is integral with the sensor through an optical path from the sensor to the detector.
37. The device of claim 36 wherein the optical path comprises an optical
fiber.
38. The device of claim 33 further comprising a plurality of reactants,
wherein each reactant is placed at at least one of the plurality of spatially distinct
locations.
39. The device of claim 33 further comprising a plurality of reactants,
wherein more than one reactant is placed at at least one of the plurality of
spatially distinct locations.
40. The device of claim 33 wherein the substrate defines a plurality of
cavities, wherein at least one cavity is placed at at least one of the plurality of
spatially distinct locations.
41. The device of claim 40 further comprising a plurality of reactants,
wherein each reactant is placed in at least one of the plurality of cavities.
42. The device of claim 40 further comprising a plurality of reactants,
wherein more than one reactant is placed in at least one of the plurality of
cavities.
43. The device of claim 33 wherein the reactant is selected from the
group consisting of a sensing particle, a receptor molecule attached to a sensing
particle, a gel or a reactive material.
44. The device of claim 43 wherein the sensing particle is selected from
the group consisting of functionalized polymeric beads, metal oxide particles, thin
polymer films, metal quantum particles, semiconductor quantum particles,
agarose, ceramic, glass, or any combination of the foregoing.
45. The device of claim 43 wherein the receptor molecule is selected
from the group consisting of signaling proteins, chemically sensitive dyes, nucleic
acid strands, nucleotide sequences, biological binding agents, antibodies,
antigens, organic metabolites, inorganic metabolites, functional group receptors,
or any combination of the foregoing.
46. The device of claim 33 wherein the substrate is comprised of glass,
plastic, silicon, resin, polymer, fiber composite, metal, metal alloy, ceramic, or any
combination of the foregoing.
47. The device of claim 33 wherein the reactant is a fluorescent based
reactant, and the light source is selected such that the frequency and wavelength
of the light compliments the excitation band of the selected fluorescent based
reactant.
48. The device of claim 33 wherein the reactant is a coiorimetric based
reactant, and the light source is a portion of the electromagnetic spectrum.
49. The device of claim 48 wherein the light source is a white light.
50. The device of claim 33 further comprising means for retrieving optical information from within the region of interest.
51. The device of claim 50 wherein the means for retrieving optical
information comprises a video monitor.
52. The device of claim 33 wherein said physical assembly is a probe.
53. The device of claim 33 wherein said physical assembly is spheroidal
in shape.
54. The device of claim 33 wherein the sensor and the detector are
integrated with a catheter to introduce the sensor and the detector to the region of
interest.
PCT/US2000/012409 1999-05-07 2000-05-08 Method and system for remotely collecting and evaluating chemical/biochemical information WO2000068670A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU49905/00A AU4990500A (en) 1999-05-07 2000-05-08 Method and system for remotely collecting and evaluating chemical/biochemical information

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13323099P 1999-05-07 1999-05-07
US60/133,230 1999-05-07

Publications (2)

Publication Number Publication Date
WO2000068670A1 true WO2000068670A1 (en) 2000-11-16
WO2000068670A9 WO2000068670A9 (en) 2002-02-21

Family

ID=22457596

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/012409 WO2000068670A1 (en) 1999-05-07 2000-05-08 Method and system for remotely collecting and evaluating chemical/biochemical information

Country Status (2)

Country Link
AU (1) AU4990500A (en)
WO (1) WO2000068670A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002093144A1 (en) * 2001-05-10 2002-11-21 Regents Of The University Of Minnesota Imaging of biological samples using electronic light detector
WO2003033728A1 (en) * 2001-10-15 2003-04-24 Dsm Ip Assets B.V. Apparatus and method for detecting undesired residues in a sample
US6784982B1 (en) 1999-11-04 2004-08-31 Regents Of The University Of Minnesota Direct mapping of DNA chips to detector arrays
WO2005019822A1 (en) * 2003-08-19 2005-03-03 Micronas Gmbh Method and device for detecting analytes
US6867851B2 (en) 1999-11-04 2005-03-15 Regents Of The University Of Minnesota Scanning of biological samples
US7304259B2 (en) 2001-11-01 2007-12-04 Siemens Energy & Automation, Inc. Mail processing system with multilevel contaminant detection and sterilization
EP2172768A1 (en) * 2008-10-06 2010-04-07 Sony Corporation A sensor for detecting an analyte
ITMI20091158A1 (en) * 2009-06-30 2011-01-01 Star Ecotronics S R L AUTOMATED SYSTEM FOR THE REVELATION OF AFLATOSSIN IN FOODS

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109849A (en) * 1983-08-30 1992-05-05 Nellcor, Inc. Perinatal pulse oximetry sensor
US5233668A (en) * 1990-05-25 1993-08-03 Suzuki Motor Corporation Method and apparatus for discriminating aggregation pattern
US5244636A (en) * 1991-01-25 1993-09-14 Trustees Of Tufts College Imaging fiber optic array sensors, apparatus, and methods for concurrently detecting multiple analytes of interest in a fluid sample
WO1998025701A1 (en) * 1996-12-11 1998-06-18 The Regents Of The University Of California Microfabricated sleeve devices for chemical reactions
WO1998029736A1 (en) * 1996-12-31 1998-07-09 Genometrix Incorporated Multiplexed molecular analysis apparatus and method
US5800341A (en) * 1994-03-30 1998-09-01 Medical Media Systems Electronically steerable endoscope
WO1998053300A2 (en) * 1997-05-23 1998-11-26 Lynx Therapeutics, Inc. System and apparaus for sequential processing of analytes

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109849A (en) * 1983-08-30 1992-05-05 Nellcor, Inc. Perinatal pulse oximetry sensor
US5233668A (en) * 1990-05-25 1993-08-03 Suzuki Motor Corporation Method and apparatus for discriminating aggregation pattern
US5244636A (en) * 1991-01-25 1993-09-14 Trustees Of Tufts College Imaging fiber optic array sensors, apparatus, and methods for concurrently detecting multiple analytes of interest in a fluid sample
US5800341A (en) * 1994-03-30 1998-09-01 Medical Media Systems Electronically steerable endoscope
WO1998025701A1 (en) * 1996-12-11 1998-06-18 The Regents Of The University Of California Microfabricated sleeve devices for chemical reactions
WO1998029736A1 (en) * 1996-12-31 1998-07-09 Genometrix Incorporated Multiplexed molecular analysis apparatus and method
WO1998053300A2 (en) * 1997-05-23 1998-11-26 Lynx Therapeutics, Inc. System and apparaus for sequential processing of analytes

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6867851B2 (en) 1999-11-04 2005-03-15 Regents Of The University Of Minnesota Scanning of biological samples
US6784982B1 (en) 1999-11-04 2004-08-31 Regents Of The University Of Minnesota Direct mapping of DNA chips to detector arrays
US7145645B2 (en) 1999-11-04 2006-12-05 Regents Of The University Of Minnesota Imaging of biological samples using electronic light detector
WO2002093144A1 (en) * 2001-05-10 2002-11-21 Regents Of The University Of Minnesota Imaging of biological samples using electronic light detector
US7736588B2 (en) 2001-10-15 2010-06-15 Dsm Ip Assets B.V. Apparatus and method for detecting undesired residues in a sample
CN1300332C (en) * 2001-10-15 2007-02-14 Dsmip资产有限公司 Apparatus and method for detecting undesired residues in a sample
WO2003033728A1 (en) * 2001-10-15 2003-04-24 Dsm Ip Assets B.V. Apparatus and method for detecting undesired residues in a sample
US7304259B2 (en) 2001-11-01 2007-12-04 Siemens Energy & Automation, Inc. Mail processing system with multilevel contaminant detection and sterilization
WO2005019822A1 (en) * 2003-08-19 2005-03-03 Micronas Gmbh Method and device for detecting analytes
EP2172768A1 (en) * 2008-10-06 2010-04-07 Sony Corporation A sensor for detecting an analyte
CN101713772B (en) * 2008-10-06 2014-04-09 索尼株式会社 Sensor for detecting analyte
ITMI20091158A1 (en) * 2009-06-30 2011-01-01 Star Ecotronics S R L AUTOMATED SYSTEM FOR THE REVELATION OF AFLATOSSIN IN FOODS
EP2270475A1 (en) * 2009-06-30 2011-01-05 Star Ecotronics S.r.l. Automated system for detecting aflatoxin in food

Also Published As

Publication number Publication date
WO2000068670A9 (en) 2002-02-21
AU4990500A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
Fang et al. Recent progress in immunosensors for pesticides
Cialla-May et al. Raman spectroscopy and imaging in bioanalytics
CN1250158C (en) Minimizing spectral effects during NIR-based blood analyte determination
US20050154277A1 (en) Apparatus and methods of using built-in micro-spectroscopy micro-biosensors and specimen collection system for a wireless capsule in a biological body in vivo
US7365849B2 (en) Portable, scanning and analyzing apparatus
US20050214863A1 (en) Method and system for the analysis of saliva using a sensor array
EP2230314A1 (en) Method of sensing an analyte
JP2004529323A (en) Method and apparatus for confining material in a micromachined chemical sensor array
CN109342391B (en) Tyrosinase activity detection method based on recyclable SERS sensor
AU2003234222A1 (en) Bio-spectral imaging system and methods for diagnosing cell disease state
WO2005113021A2 (en) Device, system and method for in-vivo analysis
JP2012247188A (en) Clinical examination using nanocarbon
Ahn et al. Emerging optical spectroscopy techniques for biomedical applications—A brief review of recent progress
WO2000068670A1 (en) Method and system for remotely collecting and evaluating chemical/biochemical information
US20040063216A1 (en) Method for detecting biomarkers
CN114540022B (en) Preparation of cellulose-based carbon quantum dot and application of cellulose-based carbon quantum dot in uric acid detection
Heise Clinical applications of near-and mid-infrared spectroscopy
WO2009008932A2 (en) Implantable wireless cmos biosensor
US11591640B2 (en) Photonic resonator absorption microscopy (PRAM) for digital resolution biomolecular diagnostics
Ranjith Premasiri et al. SERS analysis of bacteria, human blood, and cancer cells: A metabolomic and diagnostic tool
US20100179397A1 (en) Device And Method For Continuous Monitoring Of A Chemical Parameter Of An Individual
Chivukula et al. Recent advances in application of acoustic, acousto‐optic and photoacoustic methods in biology and medicine
CN103868864A (en) Sensor for detection of target of interest
CN105682689B (en) For detecting the diagnostic device of disease correlation target structure
US20060269972A1 (en) Method of diagnosing colorectal adenomas and cancer using infrared spectroscopy

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

COP Corrected version of pamphlet

Free format text: PAGES 1/3-3/3, DRAWINGS, REPLACED BY NEW PAGES 1/3-3/3; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP